Effient
Lilly’s Efient tipped for expanded NICE approval
June 20, 2014Sales and Marketing Effient, Efient, FDA, NHS, blood, lilly, longston, thinner
Eli Lilly’s anti-platelet drug Efient has been given the nod by UK healthcare watchdog NICE for more widespread use, pending …
AstraZeneca’s Brilinta delayed
September 16, 2010Sales and Marketing Brillinta, Effient, Plavix, clopidogrel
AstraZeneca’s blood thinning drug Brilinta faces an extra three month delay to its review by the FDA. The US regulator …
Effient approved in US
July 17, 2009Research and Development, Sales and Marketing Daiichi Sankyo, Effient, US, lilly
Lilly and Daaichi-Sankyo have gained US approval of their new blood clotting treatment Effient, but hopes of strong sales are …
US approval boosts Plavix competitor
July 14, 2009Research and Development, Sales and Marketing Effient, FDA, US, lilly
US regulator the FDA has approved Lilly and Daiichi Sankyo's Effient, a rival treatment to the world's best-selling blood-thinning drug …
Efient launched in the UK
April 9, 2009Research and Development, Sales and Marketing Daiichi, Effient, lilly
Lilly and Daiichi Sankyo's blood-thinning drug Efient has been launched in the UK for heart attack patients, taking on blockbuster …
Europe approves Lilly’s Plavix rival
February 25, 2009Research and Development, Sales and Marketing Daiichi, Effient, lilly
Lilly and Daiichi Sankyo have won European approval for their blood-thinning drug Efient, which will go up against established blockbuster …
Latest content
